Experienced in Ocular Toxoplasmosis

Dr. David S. Boyer

Ophthalmology
Retina Vitreous Associates Medical Group
1245 Wilshire Blvd, Suite 380, 
Los Angeles, CA 
Experienced in Ocular Toxoplasmosis
Retina Vitreous Associates Medical Group
1245 Wilshire Blvd, Suite 380, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Boyer is an Ophthalmologist in Los Angeles, California. Dr. Boyer is rated as an Experienced provider by MediFind in the treatment of Ocular Toxoplasmosis. His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy.

His clinical research consists of co-authoring 149 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Ophthalmology
Licenses
Ophthalmology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Net

Accepted plan types not found. Please verify directly with the provider.

HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

RETINA VITREOUS ASSOCIATES MEDICAL GROUP
1245 Wilshire Blvd, Suite 380, Los Angeles, CA 90017
Call: 213-483-8810

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Phase I/IIa Dose Escalation Safety and Efficacy Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium Cells Transplanted Subretinally in Patients With Advanced Dry-Form Age-Related Macular Degeneration (Geographic Atrophy)
Phase I/IIa Dose Escalation Safety and Efficacy Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium Cells Transplanted Subretinally in Patients With Advanced Dry-Form Age-Related Macular Degeneration (Geographic Atrophy)
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2026
Intervention Type: Biological
Study Drug: OpRegen
Study Phase: Phase 1/Phase 2
A Phase 2/3 Double-Masked, Randomized, 2 Stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema
A Phase 2/3 Double-Masked, Randomized, 2 Stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2026
Intervention Type: Drug
Study Drug: OCS-01 (Dexamethasone)
Study Phase: Phase 2/Phase 3
A Prospective, Single-Blind, Randomized Study to Evaluate Intravitreal Aflibercept Injection (IAI) Versus Sham as PROphylaxis Against CONversion to Neovascular Age-Related Macular Degeneration (AMD) in High-Risk Eyes
A Prospective, Single-Blind, Randomized Study to Evaluate Intravitreal Aflibercept Injection (IAI) Versus Sham as PROphylaxis Against CONversion to Neovascular Age-Related Macular Degeneration (AMD) in High-Risk Eyes
Enrollment Status: Completed
Publish Date: November 14, 2025
Intervention Type: Drug
Study Drug: Aflibercept
Study Phase: Phase 2
Phase 1, Open-Label Safety and Pharmacodynamic Study of RV001, an Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antagonist, Administered by Intravenous (IV) Infusion in Patients With Diabetic Macular Edema (DME)
Phase 1, Open-Label Safety and Pharmacodynamic Study of RV001, an Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antagonist, Administered by Intravenous (IV) Infusion in Patients With Diabetic Macular Edema (DME)
Enrollment Status: Completed
Publish Date: June 25, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Prospective, Multicenter, Randomized, Study of the Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa (RP)
A Prospective, Multicenter, Randomized, Study of the Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa (RP)
Enrollment Status: Completed
Publish Date: June 18, 2024
Intervention Type: Other, Biological
Study Drug: Human retinal progenitor cells
Study Phase: Phase 2
A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE III)
A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE III)
Enrollment Status: Active_not_recruiting
Publish Date: February 05, 2021
Intervention Type: Device
Study Phase: Not Applicable
An Exploratory, Multi-Center, Randomized, Single-Masked Study Evaluating the Effect of KPI-121 on Intraretinal or Subretinal Fluid Secondary to Retinal Vein Occlusion or Diabetic Macular Edema
An Exploratory, Multi-Center, Randomized, Single-Masked Study Evaluating the Effect of KPI-121 on Intraretinal or Subretinal Fluid Secondary to Retinal Vein Occlusion or Diabetic Macular Edema
Enrollment Status: Completed
Publish Date: December 10, 2020
Intervention Type: Drug
Study Phase: Not Applicable
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Enrollment Status: Completed
Publish Date: April 28, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials
Similar Doctors
Distinguished in Ocular Toxoplasmosis
Dr. Gary N. Holland
Ophthalmology
Distinguished in Ocular Toxoplasmosis
Dr. Gary N. Holland
Ophthalmology

Jules Stein Eye Institute Medical Group

622 W Duarte Rd, Suite 101, 
Arcadia, CA 
 (13.2 miles away)
323-442-7122
Languages Spoken:
English
See accepted insurances

Gary Holland is an Ophthalmologist in Arcadia, California. Dr. Holland is rated as a Distinguished provider by MediFind in the treatment of Ocular Toxoplasmosis. His top areas of expertise are CMV Retinitis, Uveitis, Ocular Toxoplasmosis, and Toxoplasmosis.

Distinguished in Ocular Toxoplasmosis
Dr. Andrew A. Moshfeghi
Ophthalmology
Distinguished in Ocular Toxoplasmosis
Dr. Andrew A. Moshfeghi
Ophthalmology

USC Care Medical Group Inc

1520 San Pablo St, 
Los Angeles, CA 
 (3.7 miles away)
800-872-2273
Languages Spoken:
English
See accepted insurances

Andrew Moshfeghi is an Ophthalmologist in Los Angeles, California. Dr. Moshfeghi is rated as a Distinguished provider by MediFind in the treatment of Ocular Toxoplasmosis. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Vitrectomy, and Trabeculectomy.

Advanced in Ocular Toxoplasmosis
Dr. Karen S. Morgan
Ophthalmology
Advanced in Ocular Toxoplasmosis
Dr. Karen S. Morgan
Ophthalmology

USC Care Medical Group Inc

625 S Fair Oaks Ave, 
Pasadena, CA 
 (8.6 miles away)
626-683-9000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Karen Morgan is an Ophthalmologist in Pasadena, California. Dr. Morgan is rated as an Advanced provider by MediFind in the treatment of Ocular Toxoplasmosis. Her top areas of expertise are Glaucoma, Dry Eye Syndrome, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

VIEW MORE OCULAR TOXOPLASMOSIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Boyer's expertise for a condition
ConditionClose
  • Elite
  • Age-Related Macular Degeneration (ARMD)
    Dr. Boyer is
    Elite
    . Learn about Age-Related Macular Degeneration (ARMD).
    See more Age-Related Macular Degeneration (ARMD) experts
  • Diabetic Macular Edema (DME)
    Dr. Boyer is
    Elite
    . Learn about Diabetic Macular Edema (DME).
    See more Diabetic Macular Edema (DME) experts
  • Diabetic Retinopathy
    Dr. Boyer is
    Elite
    . Learn about Diabetic Retinopathy.
    See more Diabetic Retinopathy experts
  • Geographic Atrophy
    Dr. Boyer is
    Elite
    . Learn about Geographic Atrophy.
    See more Geographic Atrophy experts
  • Late-Onset Retinal Degeneration
    Dr. Boyer is
    Elite
    . Learn about Late-Onset Retinal Degeneration.
    See more Late-Onset Retinal Degeneration experts
  • Retinal Vein Occlusion
    Dr. Boyer is
    Elite
    . Learn about Retinal Vein Occlusion.
    See more Retinal Vein Occlusion experts
  • Distinguished
  • Central Serous Chorioretinopathy
    Dr. Boyer is
    Distinguished
    . Learn about Central Serous Chorioretinopathy.
    See more Central Serous Chorioretinopathy experts
  • Choroid Plexus Carcinoma
    Dr. Boyer is
    Distinguished
    . Learn about Choroid Plexus Carcinoma.
    See more Choroid Plexus Carcinoma experts
  • Endophthalmitis
    Dr. Boyer is
    Distinguished
    . Learn about Endophthalmitis.
    See more Endophthalmitis experts
  • Retinal Artery Occlusion
    Dr. Boyer is
    Distinguished
    . Learn about Retinal Artery Occlusion.
    See more Retinal Artery Occlusion experts
  • Retinal Detachment
    Dr. Boyer is
    Distinguished
    . Learn about Retinal Detachment.
    See more Retinal Detachment experts
  • Vitrectomy
    Dr. Boyer is
    Distinguished
    . Learn about Vitrectomy.
    See more Vitrectomy experts
  • Advanced
  • Adult-Onset Vitelliform Macular Dystrophy (AVMD)
    Dr. Boyer is
    Advanced
    . Learn about Adult-Onset Vitelliform Macular Dystrophy (AVMD).
    See more Adult-Onset Vitelliform Macular Dystrophy (AVMD) experts
  • Cataract
    Dr. Boyer is
    Advanced
    . Learn about Cataract.
    See more Cataract experts
  • Cone Dystrophy
    Dr. Boyer is
    Advanced
    . Learn about Cone Dystrophy.
    See more Cone Dystrophy experts
  • Cone Rod Dystrophy Amelogenesis Imperfecta
    Dr. Boyer is
    Advanced
    . Learn about Cone Rod Dystrophy Amelogenesis Imperfecta.
    See more Cone Rod Dystrophy Amelogenesis Imperfecta experts
  • Cone-Rod Dystrophy
    Dr. Boyer is
    Advanced
    . Learn about Cone-Rod Dystrophy.
    See more Cone-Rod Dystrophy experts
  • Doyne Honeycomb Retinal Dystrophy
    Dr. Boyer is
    Advanced
    . Learn about Doyne Honeycomb Retinal Dystrophy.
    See more Doyne Honeycomb Retinal Dystrophy experts
View All 14 Advanced Conditions
  • Experienced
  • Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE)
    Dr. Boyer is
    Experienced
    . Learn about Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE).
    See more Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE) experts
  • Amblyopia
    Dr. Boyer is
    Experienced
    . Learn about Amblyopia.
    See more Amblyopia experts
  • Bietti Crystalline Dystrophy (BCD)
    Dr. Boyer is
    Experienced
    . Learn about Bietti Crystalline Dystrophy (BCD).
    See more Bietti Crystalline Dystrophy (BCD) experts
  • Birdshot Chorioretinopathy
    Dr. Boyer is
    Experienced
    . Learn about Birdshot Chorioretinopathy.
    See more Birdshot Chorioretinopathy experts
  • Blepharitis
    Dr. Boyer is
    Experienced
    . Learn about Blepharitis.
    See more Blepharitis experts
  • Cataract Removal
    Dr. Boyer is
    Experienced
    . Learn about Cataract Removal.
    See more Cataract Removal experts
View All 32 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment